Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines

Mereu, Elisabetta; Abbo, Damiano; Paradžik, Tina; Cumerlato, Michela; Bandini, Cecilia; Labrador, Maria; Maccagno, Monica; Ronchetti, Domenica; Manicardi, Veronica; Neri, Antonino; Piva, Roberto (2023) Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines. Cancers, 15 (8). ISSN 2072-6694

Preview

PDF - Published Version - article Available under License Creative Commons Attribution. Download (2MB) | Preview

Abstract

Proteasome inhibitors (PIs) are extensively used for the therapy of multiple myeloma. However, patients continuously relapse or are intrinsically resistant to this class of drugs. In addition, adverse toxic effects such as peripheral neuropathy and cardiotoxicity could arise. Here, to identify compounds that can increase the efficacy of PIs, we performed a functional screening using a library of small-molecule inhibitors covering key signaling pathways. Among the best synthetic lethal interactions, the euchromatic histone-lysine N-methyltransferase 2 (EHMT2) inhibitor UNC0642 displayed a cooperative effect with carfilzomib (CFZ) in numerous multiple myeloma (MM) cell lines, including drug-resistant models. In MM patients, EHMT2 expression correlated to worse overall and progression-free survival. Moreover, EHMT2 levels were significantly increased in bortezomib-resistant patients. We demonstrated that CFZ/UNC0642 combination exhibited a favorable cytotoxicity profile toward peripheral blood mononuclear cells and bone-marrow-derived stromal cells. To exclude off-target effects, we proved that UNC0642 treatment reduces EHMT2-related molecular markers and that an alternative EHMT2 inhibitor recapitulated the synergistic activity with CFZ. Finally, we showed that the combinatorial treatment significantly perturbs autophagy and the DNA damage repair pathways, suggesting a multi- layered mechanism of action. Overall, the present study demonstrates that EHMT2 inhibition could provide a valuable strategy to enhance PI sensitivity and overcome drug resistance in MM patients.

Item Type:	Article
Uncontrolled Keywords:	EHMT2 ; combinatorial treatment ; drug resistance ; functional screening ; multiple myeloma ; proteasome inhibitors
Subjects:	INTERDISCIPLINARY AREAS OF KNOWLEDGE > Biotechnology in Biomedicine (natural science, biomedicine and healthcare, bioethics area
Divisions:	Division of Physical Chemistry
Depositing User:	Tina Paradžik
Date Deposited:	21 Jun 2023 12:56
URI:	http://fulir.irb.hr/id/eprint/8067
DOI:	10.3390/cancers15082199

Actions (login required)

View Item